 Kathleen Woulfe
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 10 | 2024 | 980 | 1.390 |
Why?
| | Myocytes, Cardiac | 14 | 2023 | 499 | 1.370 |
Why?
| | Myofibrils | 6 | 2024 | 49 | 1.160 |
Why?
| | Calcium | 5 | 2024 | 1213 | 1.100 |
Why?
| | Heart Ventricles | 5 | 2022 | 781 | 1.060 |
Why?
| | Troponin I | 2 | 2023 | 75 | 0.840 |
Why?
| | Cytoskeleton | 1 | 2023 | 183 | 0.800 |
Why?
| | Heart Failure | 7 | 2024 | 2150 | 0.790 |
Why?
| | Microtubules | 1 | 2023 | 263 | 0.730 |
Why?
| | Heart | 4 | 2024 | 637 | 0.720 |
Why?
| | Phosphorylation | 4 | 2023 | 1713 | 0.690 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2020 | 54 | 0.680 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 210 | 0.660 |
Why?
| | Isoproterenol | 2 | 2021 | 115 | 0.630 |
Why?
| | Ventricular Remodeling | 5 | 2021 | 255 | 0.600 |
Why?
| | Geriatrics | 1 | 2018 | 81 | 0.570 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2021 | 381 | 0.560 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 179 | 0.540 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 317 | 0.540 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 527 | 0.500 |
Why?
| | Glycogen Synthase Kinase 3 | 3 | 2010 | 79 | 0.470 |
Why?
| | Heart Rate | 1 | 2018 | 802 | 0.450 |
Why?
| | Cardiomegaly | 3 | 2024 | 172 | 0.440 |
Why?
| | Pediatrics | 1 | 2018 | 1052 | 0.350 |
Why?
| | MicroRNAs | 1 | 2016 | 678 | 0.330 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2021 | 71 | 0.320 |
Why?
| | Carrier Proteins | 2 | 2023 | 743 | 0.310 |
Why?
| | Animals | 23 | 2024 | 35361 | 0.290 |
Why?
| | Sarcomeres | 3 | 2023 | 92 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 2406 | 0.280 |
Why?
| | Cardiomyopathies | 2 | 2020 | 340 | 0.250 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 132 | 0.230 |
Why?
| | Protein Processing, Post-Translational | 2 | 2024 | 455 | 0.220 |
Why?
| | Distal Myopathies | 1 | 2024 | 9 | 0.220 |
Why?
| | Boidae | 1 | 2024 | 20 | 0.220 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1706 | 0.220 |
Why?
| | Proline | 1 | 2024 | 76 | 0.210 |
Why?
| | Myocardial Contraction | 2 | 2023 | 335 | 0.210 |
Why?
| | Myocardial Infarction | 2 | 2011 | 1022 | 0.210 |
Why?
| | Amino Acid Substitution | 1 | 2024 | 282 | 0.210 |
Why?
| | Age Factors | 3 | 2021 | 3144 | 0.190 |
Why?
| | Rats | 6 | 2022 | 5500 | 0.190 |
Why?
| | Thiazepines | 1 | 2021 | 6 | 0.190 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 37 | 0.180 |
Why?
| | Serum Response Factor | 1 | 2021 | 31 | 0.180 |
Why?
| | Heart Murmurs | 1 | 2021 | 12 | 0.180 |
Why?
| | Estrogens | 1 | 2024 | 347 | 0.180 |
Why?
| | Muscle Proteins | 1 | 2022 | 220 | 0.170 |
Why?
| | Tropomyosin | 1 | 2020 | 12 | 0.170 |
Why?
| | Lysine | 2 | 2020 | 286 | 0.170 |
Why?
| | Female | 12 | 2024 | 68776 | 0.170 |
Why?
| | Mice | 13 | 2024 | 16937 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2022 | 218 | 0.170 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 132 | 0.170 |
Why?
| | Rats, Inbred Dahl | 1 | 2020 | 8 | 0.170 |
Why?
| | Troponin T | 1 | 2020 | 57 | 0.170 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 179 | 0.160 |
Why?
| | Succinic Acid | 1 | 2019 | 39 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 613 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 209 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 274 | 0.160 |
Why?
| | Acetylation | 1 | 2020 | 246 | 0.160 |
Why?
| | Cell Line | 2 | 2021 | 2781 | 0.150 |
Why?
| | Flecainide | 1 | 2018 | 7 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 697 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 345 | 0.150 |
Why?
| | Guinea Pigs | 1 | 2018 | 157 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 221 | 0.150 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 258 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 388 | 0.140 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 111 | 0.140 |
Why?
| | Gene Deletion | 2 | 2010 | 379 | 0.140 |
Why?
| | Humans | 18 | 2024 | 129650 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 248 | 0.140 |
Why?
| | Pyrroles | 2 | 2009 | 202 | 0.140 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 17 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2021 | 504 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 55 | 0.130 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.130 |
Why?
| | Myosin Heavy Chains | 2 | 2024 | 170 | 0.130 |
Why?
| | Gene Expression | 1 | 2021 | 1472 | 0.130 |
Why?
| | Male | 10 | 2024 | 63681 | 0.130 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.120 |
Why?
| | Indoles | 2 | 2009 | 387 | 0.120 |
Why?
| | Signal Transduction | 6 | 2021 | 4925 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2022 | 4063 | 0.120 |
Why?
| | Action Potentials | 1 | 2018 | 486 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2021 | 1902 | 0.120 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1033 | 0.110 |
Why?
| | Fibrosis | 1 | 2016 | 520 | 0.110 |
Why?
| | Interleukin-1 | 1 | 2016 | 958 | 0.100 |
Why?
| | Aging | 2 | 2021 | 1776 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2022 | 442 | 0.100 |
Why?
| | Mice, Knockout | 3 | 2022 | 2871 | 0.090 |
Why?
| | Group IV Phospholipases A2 | 1 | 2011 | 47 | 0.090 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2011 | 129 | 0.090 |
Why?
| | Wnt Proteins | 2 | 2007 | 127 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3717 | 0.080 |
Why?
| | Myoblasts, Cardiac | 1 | 2008 | 3 | 0.080 |
Why?
| | Exons | 1 | 2010 | 342 | 0.080 |
Why?
| | Vasoconstriction | 1 | 2010 | 199 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 429 | 0.080 |
Why?
| | Cell Division | 1 | 2010 | 797 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5440 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6556 | 0.070 |
Why?
| | Receptor Cross-Talk | 1 | 2007 | 21 | 0.070 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 262 | 0.070 |
Why?
| | Frizzled Receptors | 1 | 2007 | 23 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2009 | 191 | 0.070 |
Why?
| | Sex Factors | 2 | 2024 | 1968 | 0.070 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2007 | 126 | 0.060 |
Why?
| | Protein Binding | 2 | 2023 | 2121 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 891 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2007 | 207 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1207 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2023 | 432 | 0.060 |
Why?
| | Cardiac Myosins | 1 | 2024 | 30 | 0.060 |
Why?
| | Postprandial Period | 1 | 2024 | 104 | 0.050 |
Why?
| | Proteomics | 2 | 2021 | 1062 | 0.050 |
Why?
| | Stroke Volume | 2 | 2022 | 592 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4083 | 0.050 |
Why?
| | Myosins | 1 | 2023 | 133 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 223 | 0.050 |
Why?
| | Histone Deacetylase 6 | 1 | 2022 | 17 | 0.050 |
Why?
| | Connectin | 1 | 2022 | 31 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2024 | 317 | 0.050 |
Why?
| | Cats | 1 | 2022 | 208 | 0.050 |
Why?
| | Catecholamines | 1 | 2022 | 97 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 52 | 0.050 |
Why?
| | Rats, Transgenic | 1 | 2021 | 18 | 0.050 |
Why?
| | Rats, Inbred BN | 1 | 2021 | 58 | 0.050 |
Why?
| | Adrenergic Agents | 1 | 2021 | 6 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 315 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2024 | 422 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 75 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2391 | 0.040 |
Why?
| | Middle Aged | 3 | 2019 | 31154 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2022 | 391 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 162 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 513 | 0.040 |
Why?
| | Diastole | 1 | 2020 | 148 | 0.040 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 151 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 230 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2024 | 2119 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2024 | 737 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2020 | 186 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 874 | 0.040 |
Why?
| | Models, Biological | 2 | 2021 | 1722 | 0.040 |
Why?
| | Actins | 1 | 2020 | 411 | 0.040 |
Why?
| | Fatty Acids | 1 | 2021 | 427 | 0.040 |
Why?
| | Glycogen Synthase Kinase 3 beta | 2 | 2008 | 68 | 0.040 |
Why?
| | Child | 1 | 2016 | 20883 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 391 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 2061 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 821 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2024 | 1614 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3083 | 0.020 |
Why?
| | Misoprostol | 1 | 2011 | 17 | 0.020 |
Why?
| | Telemetry | 1 | 2011 | 39 | 0.020 |
Why?
| | Consciousness | 1 | 2011 | 25 | 0.020 |
Why?
| | Intracellular Space | 1 | 2011 | 69 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 105 | 0.020 |
Why?
| | Dinoprostone | 1 | 2011 | 186 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 169 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 316 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 354 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 86 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2009 | 68 | 0.020 |
Why?
| | Cell Size | 1 | 2008 | 89 | 0.020 |
Why?
| | Capillaries | 1 | 2009 | 103 | 0.020 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 119 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 226 | 0.020 |
Why?
| | beta-Arrestins | 1 | 2007 | 14 | 0.020 |
Why?
| | Axin Protein | 1 | 2007 | 19 | 0.020 |
Why?
| | TCF Transcription Factors | 1 | 2007 | 16 | 0.020 |
Why?
| | Arrestins | 1 | 2007 | 14 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 155 | 0.020 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 46 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2007 | 286 | 0.020 |
Why?
| | Endocytosis | 1 | 2007 | 163 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2009 | 396 | 0.020 |
Why?
| | Echocardiography | 1 | 2009 | 629 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1086 | 0.020 |
Why?
| | beta Catenin | 1 | 2007 | 223 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 811 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1097 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2007 | 399 | 0.010 |
Why?
| | Repressor Proteins | 1 | 2007 | 406 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 942 | 0.010 |
Why?
| | Mitochondria | 1 | 2009 | 877 | 0.010 |
Why?
| | Transcription Factors | 1 | 2009 | 1651 | 0.010 |
Why?
| | Blood Pressure | 1 | 2007 | 1736 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 9765 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2007 | 14518 | 0.010 |
Why?
|
|
Woulfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|